Company intelligence

OpenEvidence

Miami-based clinical AI search platform used by physicians, free and ad-supported at the point of care; raised a $250M round in September 2026 led by hospital systems and Andreessen Horowitz, its third disclosed round in under a year -- no post-money valuation was disclosed for that round, despite some secondary reports citing a $15B figure.

HealthcareMiami, Florida, USAFounded 2022Founders: Daniel NadlerWebsite ↗See connections →Compare with DatabricksSouth Florida profile →
Last verified Sep 25, 2026

Key Metrics

Valuation
$12B
As of Jan 2026Value Add Pulse research
Rumored$15B · Sep 2026 · Value Add Pulse research
Total funding
$700M+
As of Sep 25, 2026Refresh Miami

Company Snapshot

OpenEvidence is a Healthcare company, based in Miami, Florida, USA, founded 2022 by Daniel Nadler. Latest valuation $12B (As of Jan 2026, Value Add Pulse research). Total funding $700M+ (As of Sep 25, 2026).

Recent changes

  1. Sep 25, 2026Raised $250M Series C Refresh Miami
  2. Sep 25, 2026First reported total funding: $700M+ Refresh Miami
  3. Sep 25, 2026New investor: Andreessen Horowitz Refresh Miami
  4. Sep 25, 2026OpenEvidence Raises $250M Led By Andreessen Horowitz Pulse story
  5. Jan 2026Raised $250M Series D at a $12B valuation MobiHealthNews
Earlier changes (12)
  1. Jan 2026First reported valuation: $12B Value Add Pulse enrichment
  2. Jan 2026New investor: DST Global MobiHealthNews
  3. Oct 20, 2025Raised $200M Series C TechCrunch
  4. Oct 20, 2025New investor: Blackstone TechCrunch
  5. Oct 20, 2025New investor: Coatue Management TechCrunch
  6. Oct 20, 2025New investor: Google Ventures (GV) TechCrunch
  7. Oct 20, 2025New investor: Craft Ventures TechCrunch
  8. Oct 20, 2025New investor: Thrive Capital TechCrunch
  9. Oct 20, 2025New investor: Bond TechCrunch
  10. Oct 20, 2025New investor: Kleiner Perkins TechCrunch
  11. Feb 20, 2025Raised $75M Series A Tech Startups
  12. Feb 20, 2025New investor: Sequoia Capital Tech Startups

Funding History

4 events · sources dated per row
DateEventAmountValuationInvestorsSource
Sep 25, 2026Series C$250M—Pulse story
Jan 2026Series D$250M$12B
Thrive CapitalLeadunverifiedDST GlobalLeadunverified
MobiHealthNews
Oct 20, 2025Series C$200M—TechCrunch
Feb 20, 2025Series A$75M—
Sequoia Capitalunverified
Tech Startups
Funding timeline · 4 rounds · $775M tracked
$0.0M$140M$280M$75MSeries AFeb 25$200MSeries COct 25$250MSeries DJan 26$250MSeries CSep 26

Investors

Latest Pulse

  1. Health AI Raised $655M+ In Just Three DealsOpenEvidence, Precision Neuroscience and Rightway alone pulled in more than $655 million in late-September rounds, underscoring how much AI capital is now flowing into healthcare specifically.→
  2. OpenEvidence Raises $250M Led By Andreessen HorowitzOpenEvidence, the Miami-based clinical search platform for physicians, raised a new $250 million round led by hospital systems and Andreessen Horowitz.→
  3. Lightspeed Targets $250M for New India AI FundLightspeed Venture Partners is targeting $250 million for a new fund dedicated to early-stage AI startups in India, a distinct bet on the country's AI ecosystem.→
  4. One of Eight IPO Candidates Just Actually FiledCrunchbase named eight startups as 2026's clearest IPO candidates two days ago; since then, exactly one -- Oura -- has converted to an actual public S-1, while the other seven remain unfiled.→
  5. Eight Startups Racing a Closing 2026 IPO WindowCrunchbase identified eight startups -- including Anthropic, Oura, Notion, Kraken and SambaNova -- as candidates for a narrowing 2026 IPO window, with SpaceX's record June listing as the template.→
  6. Mayo's CEO Wants to Franchise Its Diagnostic BrainAxios CEO Jim VandeHei argues AI can distribute Mayo Clinic-caliber diagnostics to community hospitals, with Mayo running more than 12,000 clinical studies and building a platform to digitize its expertise for other providers.→
  7. Digital Health VC Funding Hits $7.4B in 2026Digital health venture funding reached $7.4 billion in the first half of 2026, with 19 companies raising 20 megadeals of $100 million or more -- 45% of all capital invested in the sector.→
  8. Menlo Ventures Raises $3B -- Its Largest Fund Ever -- After Its Anthropic Bet Turned Into ~$14BMenlo Ventures closed $3 billion in new capital, the largest fundraise in the firm's 50-year history, on the strength of a 2024 bet on Anthropic that is now worth roughly $14 billion. The Silicon Valley firm 'white-knuckled it' to lead a $750 million round in the AI lab two years ago; that conviction call has become one of the defining venture wins of the cycle.→

Coverage Timeline

newest first
  1. Sep 28, 2026FUNDINGHealth AI Raised $655M+ In Just Three Deals$655M+ combined→
  2. Sep 25, 2026FUNDINGOpenEvidence Raises $250M Led By Andreessen Horowitz$250M→

All Coverage

Value Add Research

Related Companies

OpenEvidence FAQ

What is OpenEvidence's valuation?

OpenEvidence's valuation is $12B (As of Jan 2026, Value Add Pulse research).

How much has OpenEvidence raised?

OpenEvidence has raised $700M+ in total funding (As of Sep 25, 2026, Refresh Miami).

Who are OpenEvidence's investors?

OpenEvidence's investors include Thrive Capital, Andreessen Horowitz, DST Global, Google Ventures (GV), Sequoia Capital, and 9 more (As of Sep 25, 2026).

Sources & methodologyshow
Where these figures come from

Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.

How we verify data · Suggest a correction